Table 4 Comparison of Groups’ socio-demographic and clinical history at baseline
Intervention group (n = 30) | Control group (n = 30) | ||
|---|---|---|---|
Mean (SD) | Mean (SD) | P | |
Age (years) | 73.4 (12.5) | 73.8 (10.1) | 0.89 |
CLU duration (weeks) | 26.4 (26.0) | 20.5 (13.4) | 0.32 |
CLU surface area (cm2) at baseline | 8.01 (10.4) | 9.2 (8.9) | 0.48 |
Sex | n (%) | n (%) | |
Male | 13 (43.3) | 12 (40.0) | 0.79 |
Female | 17 (56.6) | 18 (60.0) | 0.79 |
Ulcer type | |||
Venous | 18 (60.0) | 22 (73.0) | 0.27 |
Arterial | 5 (20.0) | 3 (10.0) | 0.45 |
Mixed | 5 (13.3) | 3 (10.0) | 0.45 |
Incompressible | 1 (3.3) | 2 (6.6) | 0.55 |
Diabetic foot ulcer | 1 (3.3) | 0 | 0.31 |
Pain medications | |||
Opiates | 17 (56.6) | 13 (40.0) | 0.30 |
NSAIDS | 4 (13.3) | 5 (16.6) | 0.72 |
Other pain meds | 21 (70.0) | 23 (76.6) | 0.56 |